Rakesh Kumar
@ca.rakesh.singhal.7960
New Delhi
5+ Years of experience
SEBI Registration INH100003282Rakesh Kumar Singhal is a Qualified Chartered Accountant. He is a SEBI Registered Research Analyst and a Certified Technical Analyst also. Believe in Value Investing and Follow CANSLIM Strategy for Momentum Investing. Having an Experience in Equity Markets for more than a decade.
Investrocker is basically the group fo ... Read more
Trade Ideas
220
Opinions
434
Followers
119k
Expertise
Quantitative
Growth
Technical
Index Strategies
Swing Trading
Market Commentary
Futures & Options
Technical Analysis
Trade Facts
Total Trades
0
Missed Trades
0
Profit Trades
0
0%Accuracy
Ask me Anything
Got a question? Ask me and I will answer it. Stay curious, stay hungry!
Posts
shared an insight ⚡️ 31st Aug
Garden Reach Shipbuilders Financial Results Analysis-Q1FY27
GRSE
Financial performance and key Operating Metrics (Consolidated) :
Operating Revenue for Q1FY27 is Rs. 1,815 Crs., 38.53% growth YoY, Total Income is Rs. 1,914 Crs., 38.47% growth YoY, Gross Profit is Rs. 443 Crs., 21.04% Negative growth YoY, EBITDA is Rs. 149 Crs., 19.1% Negative growth YoY, EBITDA Margin is 8.22% declined by 512 basis points YoY, PBT Rs. 232 Crs., 38.87% growth YoY, PAT Rs. 173 Crs. 43.82% growth YoY.
On QoQ basis Operating Revenue is down by 14.37%, Total Income is also down by 12.61%, Gross Profit is down by 59.16%, EBITDA is down by 65%, PBT is down by 43.65% and PAT is also down by 42.99%.
GRSE received Navratna status (19 Jun 2026), called a “pivotal time” as the yard is pursuing ambitious brownfield + greenfield expansion.
Order book: ₹13,596 crore : Shipbuilding: ₹12,980 crore (~95%)
Ship repair ₹96 crore; Naval vessel gun ₹219 crore; Bailey bridge ₹158 crore; Deck machinery ₹58 crore; Diesel engine plant ₹82 crore
Management cited five live tenders, total value could be plus ₹80,000 crore
NGC contract signature timing is the most immediate swing factor for replenishing the shrinking order book.
Commercial shipbuilding pivot is constrained today by physical size limits, being bridged via partnership models until greenfield/west-coast facilities come online.
Capex intensity is meaningful (₹4,400 crore across two major projects plus ₹200 crore brownfield) with multi-year gestation. shared an insight ⚡️ 31st Aug
OneSource Speciality Pharma Limited Results Analysis-Q1FY27
ONESOURCE
Financial performance and key Operating Metrics (Consolidated) :
Operating Revenue for Q1FY27 is Rs. 449 Crs., 37.2% growth YoY, Total Income is Rs. 453 Crs., 36.17% growth YoY, Gross Profit is Rs. 307 Crs., 30.87% growth YoY, EBITDA is Rs. 123 Crs., 31.57% growth YoY, But EBITDA Margin is 27.47% declined by 72 basis points YoY, PBT Rs. 20 Crs. turned profitable from loss of Rs. 4.4 Crs. YoY, PAT Rs. 25 Crs. turned profitable from loss of Rs. 0.18 Crs. YoY.
On QoQ basis Operating Revenue is down up by 4.86%, Total Income is also up by 5.23%, Gross Profit is up by 8.78%, EBITDA is up by 31.21%, PBT Rs. 20 Crs. turned profitable from loss of Rs. 0.29 Crs. QoQ, PAT is also up by 443.48%.
Revenue growth is due to semaglutide commercial launch, new MSA contracts, and also new customer wins across various businesses.
Second cartridge line commercialization is expected in the current quarter, and management claims it will “double our number of sterile days available for production.”
Company is going to be expanding both the mammalian as well as microbial capacity.”
significant increase in demand for CDMO services globally, especially in biologics, India today has got a very, very insignificant share of this. there will be enough demand for all the new capacity coming in.
Management reiterated: “FY28 outlook of $400 million organic revenue as well as EBITDA margins of 40%.” shared an insight ⚡️ 31st Aug
VOLTAS Limited Financial Results Analysis-Q1FY27
VOLTAS
Financial performance and key Operating Metrics (Consolidated) :
Operating Revenue for Q1FY27 is Rs. 4,674 Crs., 18.66% growth YoY, Total Income is Rs. 4,765 Crs., 18.51% growth YoY, Gross Profit is Rs. 1,023 Crs., 19.04% growth YoY, EBITDA is Rs. 266 Crs., 1.89% growth YoY, But EBITDA Margin is 5.68% declined by 80 basis points YoY, PBT Rs. 285 Crs., 40.81% growth YoY, PAT Rs. 213 Crs. 51.31% growth YoY.
On QoQ basis Operating Revenue is down by 4.38%, Total Income is also down by 3.36%, Gross Profit is up by 1.62%, EBITDA is up by 0.84%, PBT is up by 54.72% and PAT is also up by 87.57%.
The Company achieved a 17.3% secondary market share in RACs for FY27 upto June 2026 and widened its lead over the nearest competitor to 4 percentage points as of YTD June 2026, reinforcing its position as the undisputed market leader.
The Company also achieved the landmark milestone of selling 1 million Room Air Conditioners in just 81 days, reflecting the strength of its brand.
Unitary Cooling Products (UCP) Segment : Delivered robust growth of 33%, led by an dominant performance in the Room Air Conditioner business. RAC volumes grew 45% YoY, significantly outperforming the industry and key competitors.
Voltbek continued its strong growth trajectory in Q1 FY27, substantially outgrowing the industry and recording its highest ever quarterly sales in both value and volume. The business achieved a YTD market share of 9.4% in Washing Machines and 7.4% in Refrigerators.
The Domestic Projects business maintained strong order momentum during Q1 FY27, securing strategic wins across key growth sectors and selectively pursuing fast track and value accretive opportunities.
Engineering Products and Services Segment : Delivered high double digit topline growth, further strengthening the scale and strategic relevance of Voltas engineering products and services portfolio.FAQ's
What are the top stock recommendations by Rakesh Kumar?
Rakesh Kumar regularly shares stock views and market analysis on StockGro. Some of the stocks they have recently shared views on include GRSE, ONESOURCE and VOLTAS. Explore Rakesh Kumar's complete list of posts and trade views on their StockGro profile.
How can I follow Rakesh Kumar's latest investment insights?
You can follow Rakesh Kumar's latest investment insights, stock recommendations, and market analysis on StockGro App. Additionally, you can check their detailed stock analysis reports in the StockGro blog section.
What is Rakesh Kumar's investment strategy?
Rakesh Kumar follows a data-driven, research-backed investment strategy focused on maximizing returns while managing risk. Their approach includes fundamental and technical analysis, portfolio diversification, and sectoral trends to identify high-potential stocks.
How long has Rakesh Kumar been a SEBI-registered Research Analyst (RA)?
Rakesh Kumar has been a SEBI-registered Research Analyst and have 5+ Years of experience. With extensive experience in stock market analysis and investment research, they have guided investors in making informed and profitable decisions.
Where can I see Rakesh Kumar's past performance and stock picks?
You can check Rakesh Kumar's past stock recommendations, success rate, and investment insights on their StockGro profile. Their historical stock picks reflect a track record of strategic investment decisions based on thorough research.
How can I contact Rakesh Kumar for stock market advice?
For stock market guidance from Rakesh Kumar, you can connect through their StockGro profile. Some RAs may also provide personalized investment consultations based on their availability and SEBI regulations.
What is Rakesh Kumar's track record in predicting market movements?
Rakesh Kumar has a proven track record of accurate market analysis and trend predictions. By analyzing economic indicators, market sentiment, and technical charts, they have consistently helped investors make well-timed investment decisions.
What is the SEBI Registration number for Rakesh Kumar?
Rakesh Kumar is a SEBI-registered Research Analyst with the SEBI Registration INH100003282. This ensures that their investment recommendations comply with SEBI's regulatory framework for investor protection and financial advisory standards.
Be Financially Free with StockGro